0000899243-23-018866.txt : 20230913
0000899243-23-018866.hdr.sgml : 20230913
20230913211658
ACCESSION NUMBER: 0000899243-23-018866
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Soteropoulos Paula
CENTRAL INDEX KEY: 0001692444
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 231253914
MAIL ADDRESS:
STREET 1: 49 WINONA STREET
CITY: PEABODY
STATE: MA
ZIP: 01960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dianthus Therapeutics, Inc. /DE/
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Magenta Therapeutics, Inc.
DATE OF NAME CHANGE: 20161121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-11
0
0001690585
Dianthus Therapeutics, Inc. /DE/
DNTH
0001692444
Soteropoulos Paula
C/O DIANTHUS THERAPEUTICS, INC.
7 TIMES SQUARE, 43RD FLOOR
NEW YORK
NY
10036
1
0
0
0
0
Stock Option (Right to Buy)
11.20
2023-09-11
4
A
0
6500
0.00
A
2033-09-10
Common Stock
6500
6500
D
This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.
/s/ Adam Veness, as attorney-in-fact for Paula Soteropoulos
2023-09-13